Table 1. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Restraints

Table 3. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Trends

Table 4. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Industry Policy

Table 5. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue by Company, 2018-2023, US$ million

Table 6. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Market Share by Company, 2018-2023

Table 7. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share by Company, 2018-2023

Table 9. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Mergers & Acquisitions, Expansion Plans

Table 12. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Manufacturers Product Type

Table 13. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue by Company, 2018-2023, US$ million

Table 14. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Market Share by Company, 2018-2023

Table 15. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Import & Export Trends

Table 19. Main Sources of China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Import

Table 20. Export Destination of China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection

Table 21. Global Headquarters and Manufacturing Base of Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Manufacturers

Table 22. Global Major Manufacturers, Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Capacity Expansion and Future Plans

Table 23. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Production by Region, 2018-2023, (K Units)

Table 25. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Upstream (Raw Materials)

Table 27. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Typical Customers

Table 28. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Typical Distributors

Table 29. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Market Share, 2018-2029

Table 37. By Country, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2018-2029

Table 39. Takeda Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 40. Takeda Pharmaceutical Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 41. Takeda Pharmaceutical Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Takeda Pharmaceutical Company Profile and Main Business

Table 43. Takeda Pharmaceutical Recent Developments

Table 44. Baxter International Inc. Company Information, Head Office, Market Area and Industry Position

Table 45. Baxter International Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 46. Baxter International Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Baxter International Inc. Company Profile and Main Business

Table 48. Baxter International Inc. Recent Developments

Table 49. CSL Behring Company Information, Head Office, Market Area and Industry Position

Table 50. CSL Behring Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 51. CSL Behring Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. CSL Behring Company Profile and Main Business

Table 53. CSL Behring Recent Developments

Table 54. Bayer AG Company Information, Head Office, Market Area and Industry Position

Table 55. Bayer AG Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 56. Bayer AG Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Bayer AG Company Profile and Main Business

Table 58. Bayer AG Recent Developments

Table 59. Grifols, S.A. Company Information, Head Office, Market Area and Industry Position

Table 60. Grifols, S.A. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 61. Grifols, S.A. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Grifols, S.A. Company Profile and Main Business

Table 63. Grifols, S.A. Recent Developments

Table 64. Octapharma AG Company Information, Head Office, Market Area and Industry Position

Table 65. Octapharma AG Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 66. Octapharma AG Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Octapharma AG Company Profile and Main Business

Table 68. Octapharma AG Recent Developments

Table 69. Taibang Biologic Group Company Information, Head Office, Market Area and Industry Position

Table 70. Taibang Biologic Group Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 71. Taibang Biologic Group Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Taibang Biologic Group Company Profile and Main Business

Table 73. Taibang Biologic Group Recent Developments

Table 74. Pacific Shuanglin Bio-pharmacy Company Information, Head Office, Market Area and Industry Position

Table 75. Pacific Shuanglin Bio-pharmacy Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 76. Pacific Shuanglin Bio-pharmacy Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Pacific Shuanglin Bio-pharmacy Company Profile and Main Business

Table 78. Pacific Shuanglin Bio-pharmacy Recent Developments

Table 79. Shenzhen Weiguang Biological Products Company Information, Head Office, Market Area and Industry Position

Table 80. Shenzhen Weiguang Biological Products Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 81. Shenzhen Weiguang Biological Products Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Shenzhen Weiguang Biological Products Company Profile and Main Business

Table 83. Shenzhen Weiguang Biological Products Recent Developments

Table 84. Nanjing Pharmacare Co.,Ltd Company Information, Head Office, Market Area and Industry Position

Table 85. Nanjing Pharmacare Co.,Ltd Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 86. Nanjing Pharmacare Co.,Ltd Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Nanjing Pharmacare Co.,Ltd Company Profile and Main Business

Table 88. Nanjing Pharmacare Co.,Ltd Recent Developments

Table 89. Shanghai RAAS Company Information, Head Office, Market Area and Industry Position

Table 90. Shanghai RAAS Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 91. Shanghai RAAS Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Shanghai RAAS Company Profile and Main Business

Table 93. Shanghai RAAS Recent Developments

Table 94. Harbin Pacific Biopharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 95. Harbin Pacific Biopharmaceutical Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 96. Harbin Pacific Biopharmaceutical Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Harbin Pacific Biopharmaceutical Company Profile and Main Business

Table 98. Harbin Pacific Biopharmaceutical Recent Developments

Table 99. Hualan Biological Engineering Inc. Company Information, Head Office, Market Area and Industry Position

Table 100. Hualan Biological Engineering Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 101. Hualan Biological Engineering Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Hualan Biological Engineering Inc. Company Profile and Main Business

Table 103. Hualan Biological Engineering Inc. Recent Developments

Table 104. China Biologic Products, Inc. Company Information, Head Office, Market Area and Industry Position

Table 105. China Biologic Products, Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 106. China Biologic Products, Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. China Biologic Products, Inc. Company Profile and Main Business

Table 108. China Biologic Products, Inc. Recent Developments

Table 109. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 110. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 111. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 112. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Profile and Main Business

Table 113. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments

Table 114. Boya Bio-Pharmaceutical Group Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 115. Boya Bio-Pharmaceutical Group Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 116. Boya Bio-Pharmaceutical Group Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 117. Boya Bio-Pharmaceutical Group Co., Ltd. Company Profile and Main Business

Table 118. Boya Bio-Pharmaceutical Group Co., Ltd. Recent Developments

Table 119. ADMA Biologics, Inc. Company Information, Head Office, Market Area and Industry Position

Table 120. ADMA Biologics, Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 121. ADMA Biologics, Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 122. ADMA Biologics, Inc. Company Profile and Main Business

Table 123. ADMA Biologics, Inc. Recent Developments

Table 124. Sinopharm Group Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 125. Sinopharm Group Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications and Application

Table 126. Sinopharm Group Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 127. Sinopharm Group Co., Ltd. Company Profile and Main Business

Table 128. Sinopharm Group Co., Ltd. Recent Developments

List of Figure

Figure 1. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Picture

Figure 2. By Revenue, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Share of Global Market, 2018-2029

Figure 10. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Domestic VS Export, 2022

Figure 16. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Production Market Share & Forecast by Region, 2018-2029

Figure 19. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Industry Chain

Figure 20. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Procurement Model

Figure 21. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Model

Figure 22. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Channels, Direct Sales and Distribution

Figure 23. 1.25g

Figure 24. 2.5g

Figure 25. 5g

Figure 26. Others

Figure 27. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue, 2018-2029, US$ Million

Figure 28. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Market Share, 2018-2029

Figure 29. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Figure 30. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2018-2029

Figure 31. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Price, 2018-2029, (US$/Unit)

Figure 32. Hospitals

Figure 33. Clinics

Figure 34. Others

Figure 35. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue, 2018-2029, US$ Million

Figure 36. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Market Share, 2018-2029

Figure 37. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Figure 38. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2018-2029

Figure 39. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Price, 2018-2029, (US$/Unit)

Figure 40. By Region, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Market Share, 2018-2029

Figure 41. By Region, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2018-2029

Figure 42. North America Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 43. By Country, North America Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Market Share, 2022

Figure 44. Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country, Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Market Share, 2022

Figure 46. Asia Pacific Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country/Region, Asia Pacific Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Market Share, 2022

Figure 48. South America Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. By Country, South America Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Market Share, 2022

Figure 50. Middle East & Africa Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue & Forecasts, 2018-2029, US$ Million

Figure 51. U.S. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Figure 52. By Company, U.S. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share, 2022

Figure 53. By Type, U.S. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 54. By Application, U.S. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 55. Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Figure 56. By Company, Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share, 2022

Figure 57. By Type, Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 58. By Application, Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 59. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Figure 60. By Company, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share, 2022

Figure 61. By Type, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 62. By Application, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 63. Japan Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Figure 64. By Company, Japan Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share, 2022

Figure 65. By Type, Japan Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 66. By Application, Japan Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 67. South Korea Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Figure 68. By Company, South Korea Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share, 2022

Figure 69. By Type, South Korea Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 70. By Application, South Korea Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 71. Southeast Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Figure 72. By Company, Southeast Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share, 2022

Figure 73. By Type, Southeast Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 74. By Application, Southeast Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 75. India Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Figure 76. By Company, India Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share, 2022

Figure 77. By Type, India Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 78. By Application, India Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 79. Middle East & Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume, 2018-2029, (K Units)

Figure 80. By Company, Middle East & Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share, 2022

Figure 81. By Type, Middle East & Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 82. By Application, Middle East & Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Volume Market Share, 2022 VS 2029

Figure 83. Research Methodology

Figure 84. Breakdown of Primary Interviews

Figure 85. Bottom-up Approaches

Figure 86. Top-down Approaches